Transfusion Support of Patients with Myelodysplastic Syndromes | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Transfusion Support of Patients with Myelodysplastic Syndromes

Journal Title: 
Clinics in Laboratory Medicine
Primary Author: 
Guarente J
Guarente J, Tormey C
Original Publication Date: 
Sunday, December 31, 2023
Bone Marrow Disease(s): 

Patients with MDS often suffer from anemia, and less often thrombocytopenia, and thus are a frequently transfused population. Red blood cell (RBC) transfusion may be used to improve functional capacity and quality of life in this population, while platelet transfusion is typically used to decrease bleeding risk. Despite the frequency of transfusion in patients with MDS, there are few well-defined guidelines for RBC and platelet transfusion support in this patient population. Transfusion is not without risk-patients with MDS who are frequently transfused may develop alloantibodies to RBC antigens, which can lead to hemolytic transfusion reactions and delays in obtaining compatible RBCs. Regular communication between clinicians and blood bank physicians is crucial to ensure that patients with MDS receive the most appropriate blood products.